Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lo

Showing results (911-920 of 1,300) with videos related to

Pageof 130
Sort By:
Future Oncology (London, England)|June 21, 2014
Emerging applications of stereotactic body radiotherapySimon S Lo, Andrew Loblaw, Eric L Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 25, 2025
Stereotactic body radiotherapy for non-spine bone metastases: A meta-analysis and international stereotactic radiosurgery society (ISRS) clinical practice guidelinesTimothy K Nguyen, Alexander V Louie, Rupesh Kotecha, et al.
Expert Review of Anticancer Therapy|December 3, 2008
Stereotactic body radiation therapy for nonpulmonary primary tumorsSimon S Lo, Higinia R Cardenes, Bin S Teh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosisF Patti, M P Amato, S Bastianello, et al.
Pflugers Archiv : European Journal of Physiology|March 14, 2003
UCP3 protein expression is lower in type I, IIa and IIx muscle fiber types of endurance-trained compared to untrained subjectsA P Russell, G Wadley, M K C Hesselink, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2009
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) studyF Patti, M P Amato, M Trojano, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical studyS Stacchiotti, N Simeone, S Lo Vullo, et al.
Technology in Cancer Research & Treatment|August 3, 2018
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and ControversiesStephanie K Schaub, Pehr E Hartvigson, Michael I Lock, et al.
Cancer Discovery|January 26, 2023
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in MelanomaPrashanthi Dharanipragada, Xiao Zhang, Sixue Liu, et al.
Nature Reviews. Clinical Oncology|May 25, 2011
The role of local therapy in the management of lung and liver oligometastasesSimon S Lo, Susan D Moffatt-Bruce, Laura A Dawson, et al.
Pageof 130

Showing results (911-920 of 1,300) with videos related to

Sort By:
Pageof 130
Future Oncology (London, England)|June 21, 2014
Emerging applications of stereotactic body radiotherapySimon S Lo, Andrew Loblaw, Eric L Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 25, 2025
Stereotactic body radiotherapy for non-spine bone metastases: A meta-analysis and international stereotactic radiosurgery society (ISRS) clinical practice guidelinesTimothy K Nguyen, Alexander V Louie, Rupesh Kotecha, et al.
Expert Review of Anticancer Therapy|December 3, 2008
Stereotactic body radiation therapy for nonpulmonary primary tumorsSimon S Lo, Higinia R Cardenes, Bin S Teh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosisF Patti, M P Amato, S Bastianello, et al.
Pflugers Archiv : European Journal of Physiology|March 14, 2003
UCP3 protein expression is lower in type I, IIa and IIx muscle fiber types of endurance-trained compared to untrained subjectsA P Russell, G Wadley, M K C Hesselink, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2009
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) studyF Patti, M P Amato, M Trojano, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical studyS Stacchiotti, N Simeone, S Lo Vullo, et al.
Technology in Cancer Research & Treatment|August 3, 2018
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and ControversiesStephanie K Schaub, Pehr E Hartvigson, Michael I Lock, et al.
Cancer Discovery|January 26, 2023
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in MelanomaPrashanthi Dharanipragada, Xiao Zhang, Sixue Liu, et al.
Nature Reviews. Clinical Oncology|May 25, 2011
The role of local therapy in the management of lung and liver oligometastasesSimon S Lo, Susan D Moffatt-Bruce, Laura A Dawson, et al.
Pageof 130